Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 165.22B | 130.50B | 60.92B | 26.97B | 26.91B | 16.68B |
Gross Profit | 115.40B | 97.86B | 44.30B | 15.36B | 17.48B | 10.40B |
EBITDA | 99.70B | 86.14B | 35.58B | 5.99B | 11.35B | 5.69B |
Net Income | 86.60B | 72.88B | 29.76B | 4.37B | 9.75B | 4.33B |
Balance Sheet | ||||||
Total Assets | 140.74B | 111.60B | 65.73B | 41.18B | 44.19B | 28.79B |
Cash, Cash Equivalents and Short-Term Investments | 56.79B | 43.21B | 25.98B | 13.30B | 21.21B | 11.56B |
Total Debt | 10.60B | 10.27B | 11.06B | 12.03B | 11.83B | 7.72B |
Total Liabilities | 40.61B | 32.27B | 22.75B | 19.08B | 17.57B | 11.90B |
Stockholders Equity | 100.13B | 79.33B | 42.98B | 22.10B | 26.61B | 16.89B |
Cash Flow | ||||||
Free Cash Flow | 72.02B | 60.85B | 27.02B | 3.81B | 8.13B | 4.69B |
Operating Cash Flow | 77.03B | 64.09B | 28.09B | 5.64B | 9.11B | 5.82B |
Investing Cash Flow | -23.89B | -20.42B | -10.57B | 7.38B | -9.83B | -19.68B |
Financing Cash Flow | -50.08B | -42.36B | -13.63B | -11.62B | 1.86B | 3.80B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | 337.52B | 33.63 | 53.44% | 0.78% | 27.09% | 40.94% | |
80 Outperform | $4.14T | 49.77 | 109.42% | 0.02% | 71.55% | 64.54% | |
77 Outperform | 258.29B | 91.61 | 4.75% | ― | 27.17% | 108.67% | |
77 Outperform | 1.63T | 91.97 | 25.84% | 0.66% | 28.01% | 235.66% | |
77 Outperform | 1.09T | 29.83 | 27.36% | 1.10% | 38.65% | 57.18% | |
75 Outperform | 163.92B | 32.47 | 28.39% | 3.02% | 3.62% | -5.27% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |